Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (3231)	4/29/2015 6:21:50 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

ISR was up 16.33% and is up another 2.92% AHs.<g> Volume of 3,165,427 was > 5x its ADV. <g> The presentation at the ABS in Orlando was 3 weeks ago. I don't know what triggered today's spike.<g> bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (3231)	4/30/2015 12:20:45 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 3722

<<The problem is that the analyst are already expecting for it to report $2.32 a share for the quarter, about 57% > $1.48 last Yr., and could find problems if it misses by a few pennies. <g>>> Everyone is LOOKING for excuse to sell (from profit, or short side). Do you think that BIB will hold 152 level? GILD sale will be in line (somehow my view), but it is view of the next TWO Q (that is how far this market is looking) that will shape near term trend (or post ASCO expectation). I bought little GILD (as trading)..just to keep me occupied. <g>